Attached files

file filename
EX-3.1 - CERTIFICATE OF AMENDMENT - Rapid Therapeutic Science Laboratories, Inc.exhibit31.htm

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 6, 2017

 

PowerMedChairs

(Exact Name of Registrant as Specified in Charter)

Nevada   000-55018   46-2111820
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)
         
8221 E. Washington Street, Chagrin Falls, OH
(Address of Principal Executive Offices)
(Zip Code)

(440) 543-4645
(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

Item 5.03. Amendments to Articles of Incorporation or Bylaws.

 

On May 30, 2017, PowerMedChairs (the "Company") filed Articles of Amendment to its Amended Articles of Incorporation (the "Articles of Amendment") with the Secretary of State of the State of Nevada effecting a name change of the Company to Holly Brothers Pictures, Inc. (the "Corporate Action"). The Corporate Action and the Amended Articles became effective on June 6, 2017, following compliance with notification requirements of the Financial Industry Regulatory Authority.

 

A copy of the Articles of Amendment is attached hereto as Exhibit 3.1 and incorporated by reference herein. The new CUSIP number for the Company's common stock is 435736 103.

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

The disclosures set forth in Item 5.03 above are incorporated by reference into this Item 5.07.

 

On April 25, 2017 (the "Record Date"), the Company obtained written consent by the holder of the majority of the voting power of the Company's capital stock approving the Corporate Action.

  

Item 7.01 Regulation FD Disclosure.

 

The information contained in this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or be otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 8.01 Other Events.

 

On June 6, 2017, the Financial Industry Regulatory Authority (FINRA) approved the Corporate Action. The Company's stock is quoted on the OTCQB under the ticker symbol PCHA, but beginning June 7, 2017, the Company's common stock will begin trading under the symbol HLLY.

 

Item 9.01 Financial Statement and Exhibits.

 

(d) Exhibits.

 

The following documents are filed herewith:

 

Exhibit No. Description

 

Exhibit 3.1 Certificate of Amendment of Certificate of Incorporation

 
 

 

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    PowerMedChairs
June 6, 2017  

By: /s/ Anton Yeranossian
Anton Yeranossian

Chief Executive Officer